Europe is a matured and highly regulated market. Increasing meat consumption, food safety concerns and improving meat prices in the European continent are important drivers for the growth of the anticoccidial market. There is also the rise in companion animal spending that is contributing to the growth of the anticoccidial market. In the European market countries like Spain, United Kingdom, Italy, Germany and France are the top runners for driving the market. And the market revenue is set to grow at a CAGR of 3.5% by the year 2021.Spain, UK and France combined have contributed close to 46 % of the total revenue for the year 2012 and these markets are expected to grow by a CAGR of 3.4% during the projected time frame.
The Market research report titled EuropeAnticoccidial Drugs Market In Animal Health - Trends And Forecasts - (2016-21) by MORDOR INTELLIGENCEcategorizes the global anticoccidial market on the basis of Animal Types (Poultry, Cattle, Swine, and companion animals), by Drugs (Ionophore anticoccidials, Chemical derivative anticoccidials and Antibiotic anticoccidials) and by Geography (Spain, UK, France, Germany, Italy and Others).
Key players in the Anticoccidial Drugs Market are Zoetis, Elanco (A division of Eli Lilly and Company), Merial, Bayer Health care Animal Healthcare division, Merck Animal Healthcare, Boehringer Ingelheim Animal Health, Virbac, and Novartis Animal Healthcare.
What the report offers:
Market Definition for the specified topic along with identification of key drivers and restraints for the market.